...
首页> 外文期刊>Neoplasia: an international journal for oncology research >Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy
【24h】

Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy

机译:胶质瘤形成的机制:迭代血管外胶质瘤生长和侵袭导致肿瘤进展,VEGF无关的血管化,以及抗脑化治疗的抗性

获取原文
           

摘要

As glioma cells infiltrate the brain they become associated with various microanatomic brain structures such as blood vessels, white matter tracts, and brain parenchyma. How these distinct invasion patterns coordinate tumor growth and influence clinical outcomes remain poorly understood. We have investigated how perivascular growth affects glioma growth patterning and response to antiangiogenic therapy within the highly vascularized brain. Orthotopically implanted rodent and human glioma cells are shown to commonly invade and proliferate within brain perivascular space. This form of brain tumor growth and invasion is also shown to characterize de novo generated endogenous mouse brain tumors, biopsies of primary human glioblastoma (GBM), and peripheral cancer metastasis to the human brain. Perivascularly invading brain tumors become vascularized by normal brain microvessels as individual glioma cells use perivascular space as a conduit for tumor invasion. Agent-based computational modeling recapitulated biological perivascular glioma growth without the need for neoangiogenesis. We tested the requirement for neoangiogenesis in perivascular glioma by treating animals with angiogenesis inhibitors bevacizumab and DC101. These inhibitors induced the expected vessel normalization, yet failed to reduce tumor growth or improve survival of mice bearing orthotopic or endogenous gliomas while exacerbating brain tumor invasion. Our results provide compelling experimental evidence in support of the recently described failure of clinically used antiangiogenics to extend the overall survival of human GBM patients.
机译:随着胶质瘤细胞渗透脑,它们与各种微杀虫脑结构相关的脑,如血管,白质龟和脑实质。这些不同的侵袭模式如何坐标肿瘤生长,影响临床结果仍然明显。我们已经研究了衰减程度的增长如何影响胶质瘤生长图案和对高血管化脑中的抗血管生成治疗的反应。原位植入的啮齿动物和人胶质瘤细胞显示在脑血管外空间内通常侵入和增殖。这种形式的脑肿瘤生长和侵袭也显示为表征De Novo产生的内源性小鼠脑肿瘤,原发性人胶质母细胞瘤(GBM)的活组织检查,以及对人脑的外周癌转移。随着个体胶质瘤细胞使用脑血管空间作为肿瘤侵袭的导管,血管内侵袭脑肿瘤的血管化被正常的脑微血管血管化。基于代理的计算建模综合综合生物血管胶质瘤生长而不需要新谐振发生。我们通过用血管生成抑制剂Bevacizumab和DC101治疗动物来测试脑血管胶质瘤中新生瘤的要求。这些抑制剂诱导预期的血管标准化,但未能降低肿瘤生长或改善患有原位或内源性胶质瘤的小鼠的存活,同时加剧脑肿瘤侵袭。我们的结果提供了令人信服的实验证据,以支持最近描述的临床用过抗岩病毒失败,以延长人GBM患者的整体存活。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号